Page last updated: 2024-10-29

iohexol and Diffuse Parenchymal Lung Disease

iohexol has been researched along with Diffuse Parenchymal Lung Disease in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research Excerpts

ExcerptRelevanceReference
"To investigate the effect of diffuse interstitial lung disease (DILD) on the image quality of computed tomographic pulmonary angiography (CTPA)."1.38Image quality of computed tomographic pulmonary angiography for suspected pulmonary embolus in patients with diffuse interstitial lung disease. ( Hansell, DM; Walsh, SL; Wells, AU; Wijesekera, NT, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wijesekera, NT1
Walsh, SL1
Wells, AU1
Hansell, DM1

Other Studies

1 other study available for iohexol and Diffuse Parenchymal Lung Disease

ArticleYear
Image quality of computed tomographic pulmonary angiography for suspected pulmonary embolus in patients with diffuse interstitial lung disease.
    Journal of thoracic imaging, 2012, Volume: 27, Issue:3

    Topics: Angiography; Artifacts; Chi-Square Distribution; Contrast Media; Female; Humans; Iohexol; Lung Disea

2012